Ambryon Biosciences

pCAG-GFP

Mammalian expression plasmid in which a CAG promoter (CMV enhancer, chicken β-actin promoter and a chimeric intron) drives EGFP, followed by a rabbit β-globin polyadenylation signal. Deposited by the Cepko lab as Addgene #11150 on a pCAGEN backbone; it is the GFP vector Matsuda and Cepko used to electroporate neonatal rodent retina.

Characteristics

5,563 bp circular plasmid with ampicillin resistance in bacteria. The file annotates no AAV inverted terminal repeats, so despite the pAAV-CAG-GFP name a citing paper gave it, this is a plasmid and not an AAV transfer vector. In the originating paper, pCAG-GFP given at postnatal day 0 produced GFP in about 80% of electroporated rat retinae and 50% of mouse retinae, and the GFP persisted to at least postnatal day 50.

Applications

Expressing GFP from the CAG promoter to label cells, for example by in vivo electroporation of neonatal rodent retina or in vitro electroporation of retinal explants. Others used pCAG-GFP (Addgene #11150) as: (1) an electroporation marker and control in the developing mouse brain and eye: co-electroporated in utero to identify electroporated embryos under a fluorescence stereoscope (Nature 2019, 10.1038/s41586-019-1166-7), delivered by in utero electroporation of mouse cortex (S1, S2, auditory cortex; 1 µg/µl, Nat Commun 2019, 10.1038/s41467-019-12495-w), and used as the control plasmid in subretinal electroporation of postnatal mouse eye, where 26.0 ± 3.3% of GFP+ cells lay in the inner nuclear layer (Dev Biol 2017, 10.1016/j.ydbio.2017.09.030); (2) a co-electroporated reporter in mouse tibialis anterior muscle (15 µg per injection) in a Cas9 gene-editing study (Nat Methods 2016, 10.1038/nmeth.3993); (3) a GFP source for the GFP-dependent Cre system CRE-DOG, transfected into 293T cells to induce Cre activity (Nat Neurosci 2015, 10.1038/nn.4081); (4) a transfection control in HEK-293FT cells (Nature 2014, 10.1038/nature13321); (5) a backbone: Pax6 constructs were cloned into pCAG-GFP (10.1016/j.ydbio.2017.09.030), the EGFP was replaced with hChR2(H134R)-EYFP to make pCAG-hChR2(H134R)-EYFP (eLife 2018, 10.7554/elife.38506), and its GFP was fused to a C4 sequence (PLoS Biol 2019, 10.1371/journal.pbio.3000604).

Payload28 features

in a 5,563 bp deposit · 5 features outside the design

0100020003000pCAG-GFPPlasmid DNA · 56% GCCMV enhancer · enhancer · 31–410 · 380 bpCMV enhancerchicken beta-actin promoter · promoter · 412–689 · 278 bpchicken beta-acti…chimeric intron · intron · 690–1,706 · 1,017 bpchimeric intronKozak sequence · regulatory · 1,799–1,808 · 10 bpKozak sequenceEGFP · CDS · 1,805–2,524 · 720 bpEGFPEGFP · CDS · 1,805–2,521 · 717 bpEGFPbeta-globin poly(A) signal · polyA signal · 2,676–2,731 · 56 bpbeta-globin poly(…lac operator · protein bind · 3,116–3,132 · 17 bplac operatorlac promoter · promoter · 3,140–3,170 (reverse) · 31 bplac promoterCAP binding site · protein bind · 3,185–3,206 · 22 bpCAP binding siteSV40 promoter · promoter · 3,265–3,460 · 196 bpSV40 promoterSV40 ori · origin · 3,311–3,446 · 136 bpSV40 oriSV40 poly(A) signal · polyA signal · 3,466–3,600 · 135 bpSV40 poly(A) sign…CAG promoter (CMV enhancer, β-actin promoter, intron) · promoter · 31–1,706 · 1,676 bpCAG promoter (CMV…0100020003000pCAG-GFPPlasmid DNA · 56% GCCMV enhancer · enhancer · 31–410 · 380 bpCMV enhancerchicken beta-actin promoter · promoter · 412–689 · 278 bpchicken beta-actin prom…chimeric intron · intron · 690–1,706 · 1,017 bpchimeric intronKozak sequence · regulatory · 1,799–1,808 · 10 bpKozak sequenceEGFP · CDS · 1,805–2,524 · 720 bpEGFPEGFP · CDS · 1,805–2,521 · 717 bpEGFPbeta-globin poly(A) signal · polyA signal · 2,676–2,731 · 56 bpbeta-globin poly(A) sig…lac operator · protein bind · 3,116–3,132 · 17 bplac operatorlac promoter · promoter · 3,140–3,170 (reverse) · 31 bplac promoterCAP binding site · protein bind · 3,185–3,206 · 22 bpCAP binding siteSV40 promoter · promoter · 3,265–3,460 · 196 bpSV40 promoterSV40 ori · origin · 3,311–3,446 · 136 bpSV40 oriSV40 poly(A) signal · polyA signal · 3,466–3,600 · 135 bpSV40 poly(A) signalCAG promoter (CMV enhancer, β-actin promoter, intron) · promoter · 31–1,706 · 1,676 bpCAG promoter (CMV enhan…0500100015002000250030003500pCAG-GFPPlasmid DNA · 56% GCCMV enhancer · enhancer · 31–410 · 380 bpCMV enhancerchicken beta-actin promoter · promoter · 412–689 · 278 bpchicken beta-actin promoterchimeric intron · intron · 690–1,706 · 1,017 bpchimeric intronKozak sequence · regulatory · 1,799–1,808 · 10 bpKozak sequenceEGFP · CDS · 1,805–2,524 · 720 bpEGFPEGFP · CDS · 1,805–2,521 · 717 bpEGFPbeta-globin poly(A) signal · polyA signal · 2,676–2,731 · 56 bpbeta-globin poly(A) signallac operator · protein bind · 3,116–3,132 · 17 bplac operatorlac promoter · promoter · 3,140–3,170 (reverse) · 31 bplac promoterCAP binding site · protein bind · 3,185–3,206 · 22 bpCAP binding siteSV40 promoter · promoter · 3,265–3,460 · 196 bpSV40 promoterSV40 ori · origin · 3,311–3,446 · 136 bpSV40 oriSV40 poly(A) signal · polyA signal · 3,466–3,600 · 135 bpSV40 poly(A) signalCAG promoter (CMV enhancer, β-actin promoter, intron) · promoter · 31–1,706 · 1,676 bpCAG promoter (CMV enhancer, β-a…

Sequence3,838 bp

Sign in to view the full sequence.

Sign in

References

  1. 1.Matsuda et al. (2003). Electroporation and RNA interference in the rodent retina in vivo and in vitro. Proceedings of the National Academy of Sciences — Matsuda 2003 Retinal Electroporation

Identifiers & revision